Invention Grant
- Patent Title: Diacylglycerol acyltransferase 2 inhibitors
- Patent Title (中): 二酰基甘油酰基转移酶2抑制剂
-
Application No.: US14384508Application Date: 2013-03-26
-
Publication No.: US09296745B2Publication Date: 2016-03-29
- Inventor: Kay Ahn , Markus Boehm , Shawn Cabral , Philip A. Carpino , Kentaro Futatsugi , David Hepworth , Daniel W. Kung , Suvi Orr , Jian Wang
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Lisa A. Samuels
- International Application: PCT/IB2013/052404 WO 20130326
- International Announcement: WO2013/150416 WO 20131010
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K45/06 ; C07D487/04 ; C07D519/00 ; A61K31/437 ; A61K31/506 ; A61K31/52 ; A61K31/5377 ; A61K31/538
Abstract:
Derivatives of purine, 3H-imidazo[4,5-b]pyrimidine and 1H-imidazo[4,5-d]pyrazine of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
Public/Granted literature
- US20150087585A1 DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS Public/Granted day:2015-03-26
Information query
